• The document is a transcript of the Q1 FY27 Earnings Conference Call held on August 17, 2026, discussing financial results and business performance for the quarter ended June 30, 2026.
  • The call was hosted by management including Mr. Mahesh Makhija (Chairman and Managing Director) and Mr. Mohit Tamhankar (Director, Compliance).
  • The stated purpose was to share key operating and financial highlights followed by a Q&A session with analysts and investors.
  • Management participants confirmed that no unpublished price sensitive information (UPSI) would be shared during the call.
  • The company's financial results and investor presentation were uploaded on stock exchanges and the company website for reference.

Financial Highlights Discussed

  • Q1 FY27 Consolidated Revenue: INR 56.9 crores, representing 22% year-on-year growth
  • Q1 FY27 EBITDA: INR 8.3 crores, with 27% year-on-year growth and margin improvement to 14.6% from 14.1% in Q1 FY26
  • Q1 FY27 PAT: Approximately INR 4 crores, with 25% year-on-year growth and PAT margin of 7%
  • Sequential Performance: Revenue increased 28% quarter-on-quarter, EBITDA grew 41% quarter-on-quarter, and PAT more than doubled (110% increase) over Q4 FY26
  • Service Business Revenue: INR 17.6 crores from PSP business (including subsidiary Saarathi Healthcare) and INR 6.4 crores from B2B health camps
  • Q-Devices Revenue: Approximately INR 3 crores in Q1 FY27

Business Updates and Guidance

  • The company successfully migrated from SME platform to main board of NSE on June 18, 2026
  • Currently holds 76% stake in Saarathi Healthcare, with plans to acquire remaining stake by end of Q2 FY27
  • Conducted 11,497 B2B health camps in Q1 FY27, representing 40% increase over previous quarter
  • Proprietary technology platform supports 100+ programs and more than 1 million patients
  • Full-year FY27 service revenue guidance maintained at INR 90-100 crores
  • Full-year FY27 EBITDA margin guidance maintained at approximately 18%
  • Q-Devices targeted to contribute 20-25% of total product revenue in next 3 years

Additional Notes Section

  • The transcript includes detailed Q&A session with analysts from Trinetra Asset Managers, Sagari Capital, Stellar AMC, and individual investors
  • The document represents a compliance filing with the National Stock Exchange of India Limited
  • No financial data was disclosed in the announcement itself beyond what was discussed in the earnings call